We live in an era where people around the world are dying from untreatable infections due to the emergence and spread of antibiotic resistance.
Widespread use of antibiotics, plus the natural growth of bacteria over time, has provoked the emergence of dangerous multidrug-resistant (MDR) bacteria, rendering even the most effective drugs ineffective, creating challenges for all levels of care within global healthcare systems.
ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species) are capable of “escaping” the biocidal action of antimicrobial agents, are the leading cause of nosocomial infections throughout the world and are among the most prevalent bacteria in chronic cutaneous infections.
Bacteriophages: Viruses that Selectively Kill Bacteria
Memsel is developing next-generation wound healing solutions containing encapsulated and stabilized bacteriophage cocktails that will prevent and treat wound infections, offering a natural, safe, and effective strategy to control MDR bacteria and ESKAPE pathogens.
Bacteriophages are the ultimate antibiotic, evolving with mutating bacteria, nullifying the risk of acquired bacteria resistance and countering MDR bacteria.
Bacteriophage attach to select bacterium, injecting its DNA into the bacterial cell. The bacterium then ruptures,, releasing multiple new bacteriophages to seek and attack more bacteria.
Bacteriophages are on constant patrol to kill bacteria and prevent the onset of infection.